Npk Medical Trading Inc.
Business Opportunity Assessment Report

Company Snapshot

NPK Medical Trading Inc. is a Philippines-based trading company headquartered in Quezon City, Metro Manila, operating primarily as a medical equipment distributor. It functions as an intermediary between international manufacturers and end-users or regional buyers, with no evidence of manufacturing capability. Its business structure centers on importing diagnostic and therapeutic devices, notably ultrasound systems and related components, with strong ties to Korean and Russian suppliers. A notable shift occurred in early 2024, when transaction volume spiked dramatically—peaking at 35,496.9 units in February 2026—indicating intensified procurement activity or a major project-driven order cycle.

Company Attribute Information

• Company Name: NPK Medical Trading Inc.
• Data Source: EMIS Company Profile, proprietary customs data (2023–2026)
• Country of Origin: Philippines
• Address: 62 Cordillera Street, Quezon City, Metro Manila
• Core Products: Ultrasound systems (HS 901812), medical control panels (HS 903300), other diagnostic imaging parts (HS 901890)
• Company Type: Distributor

Trade Trend Analysis

Data interpretation reveals extreme temporal concentration: over 70% of total transaction volume (35,496.9 units) occurred in a single month (Feb 2026), dwarfing all other months—most of which range between 140–900 units. This outlier suggests either a one-off bulk procurement (e.g., government tender fulfillment or pandemic-related emergency supply) or data anomaly. Transaction frequency remains consistently high (69–221 monthly), indicating stable operational cadence outside the outlier month. The sustained presence across 36+ months confirms institutional continuity—not a transient or speculative entity. This pattern signals high dependency on episodic large-scale orders rather than steady recurring demand.

Trade Partner Analysis

Data interpretation shows overwhelming dominance by Samsung Medison Co., Ltd. (Russia), accounting for 75.09% of all transactions—far exceeding any other partner. This extreme concentration indicates NPK’s role as a dedicated channel or authorized distributor for Samsung Medison in the Philippines or adjacent markets. Secondary partners (Pentax, Huntleigh, Alsa) are globally recognized OEMs—but collectively represent only ~13% of activity. Notably, several South Korean suppliers (Daiwha, Mediana, CU Medical) appear repeatedly but show mixed status—some maintained, others lost—suggesting portfolio rationalization or shifting commercial alignment. This reflects high counterparty risk due to extreme reliance on a single supplier.

HS Code Analysis

Data interpretation highlights sharp product focus: HS 90181200000 (ultrasound diagnostic apparatus) alone accounts for 62.59% of all transactions—confirming ultrasound systems as the absolute core product line. HS 90330000000 (electrical control panels for medical devices) and HS 90189090000 (other medical imaging parts) form complementary categories, together comprising ~16% of activity. All top-10 HS codes fall under Chapter 90 (optical, photographic, measuring, checking, precision, medical instruments), confirming strict specialization in regulated medical diagnostics—not general healthcare consumables or pharmaceuticals. This signals regulatory compliance exposure and narrow technical competency scope.

Trade Region Analysis

Data interpretation shows geographic duality: South Korea (including ‘Korea’ and ‘South Korea’ entries totaling >62% of activity) and Russia (via multiple entities including Samsung Medison and Beijing Aeonmed) jointly dominate sourcing—reflecting dual-sourcing strategy across two key manufacturing hubs. Singapore, Italy, England, and China serve as secondary but stable channels—each contributing 2–3% and maintaining recent activity. The Philippines appears only as a domestic logistics node (‘South Korean Shippers’, ‘China Shippers’) but not as a source—consistent with its role as importer/distributor, not local manufacturer. This reflects strategic diversification across geopolitical risk zones—yet retains heavy exposure to East Asian supply chains.

Export Port Analysis

Data interpretation shows complete absence of active export port usage since late 2024—Manila, Akron-Canton, and Clarksville ports all marked “Lost” with last activity in November 2024. This aligns with NPK’s confirmed role as an importer (not exporter): all customs records reflect inbound shipments. The port data likely captures misclassified or legacy logistics tags—not actual outbound operations. No current port activity supports the conclusion that NPK does not engage in export trade. This confirms pure import-distribution orientation with zero export footprint.

Contact Information

• Official Website: www.npkmedical.ph
• Head Office Address: 62 Cordillera Street, Quezon City, Metro Manila, Philippines
• Industry Classification: Medical Equipment Distribution (EMIS)
• Social Media: No verified LinkedIn, Facebook, or Twitter profiles found.
• Email/Phone: Not publicly disclosed in available sources.

Company Trade Summary

• Dominant focus on ultrasound diagnostic systems (HS 901812), representing >62% of all procurement activity.
• Extreme supplier concentration: Samsung Medison accounts for 75% of transactions—indicating channel exclusivity or deep OEM partnership.
• Sourcing heavily weighted toward South Korea and Russia—two critical but geopolitically sensitive medical device manufacturing bases.
• No verifiable export activity; exclusively imports—consistent with distributor profile.
• Transaction volume exhibits one massive outlier (Feb 2026), suggesting event-driven demand rather than organic growth trend.